Schonfeld Strategic Advisors LLC Infinity Pharmaceuticals, Inc. Transaction History

Schonfeld Strategic Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.49 - $1.2 $49 - $120	100 Added 0.95%	10,600 $6,000
Q1 2022 May 16, 2022	BUY	$0.85 - $2.4 $8,925 - $25,200	10,500 New	10,500 $12,000
Q2 2018 Aug 14, 2018	SELL	$1.72 - $2.26 $479,496 - $630,036	-278,777 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$1.8 - $2.74 $501,798 - $763,848	278,777 New	278,777 $585,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.